Carina Vingsbo Lundberg

Research area

Preclinical evaluation of antimicrobial drugs in in vivo infection models.

Responsibilities

Head of contract research

Publications

• Marie Olliver, Laura Griestop, Diarmaid Hughes, Anna Karin Belfrage, Johan Gising, Pawel Baranczewski, Carina Vingsbo Lundberg, Anders Karlén. ENABLE: an engine for European antibacterial drug discovery and development. Nat Rev Drug Discov. 2021 Jun;20(6):407-408
  
  
• Tomás Sou, Jon Hansen, Edgars Liepinsh, Maria Backlund, Onur Ercan, Solveiga Grinberga, Cao Sha, Anna Petersson, Magdalena Tomczak, Malgorzata Urbas, Dorota Zabicka, Carina Vingsbo Lundberg, Diarmaid Hughes, Sven N. Hobbie, Lena E. Friberg. Model-informed drug development for antimicrobials: Translational PK and PK/PD modeling to predict an efficacious human dose for apramycin. Clin Pharmacol Ther. 2021 Apr;109(4):1063-1073
  
  
• Alysha Elliott, Johnny Huang, Søren Neve, Johannes Zuegg, Ingrid Edwards, Amy Cain, Christine Boinett, Lars Barquist, Carina Vingsbo Lundberg, Jason Steen, Mark Butler, Mehdi Mobil, Kaela Porter, Mark Blaskovich, Sergio Lociuro, Magnus Strandh, Matthew A. Cooper. An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria. Nat Commun. 2020 Jun 23;11(1):3184
  
  
• Thomas Tängdén, Carina Vingsbo Lundberg, Lena E. Friberg, Angela Huttner. How preclinical infection models help define antibiotic doses in the clinic. Int J Antimicrob Agents. 2020 Aug;56(2):106008